Phase
Condition
Gout (Hyperuricemia)
Treatment
N/AClinical Study ID
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Signed informed consent prior to any study-related procedures
Age 18-80 years old
BMI range 18.5-35 kg/m2
Blood uric acid above 0.36 mmol/L (6 mg/dl)
Willing to abstain from regular consumption of probiotic supplements or foodproducts containing probiotic bacteria (including fermented food and beverages),until collection of faecal material
Willing to abstain from regular consumption of supplements and medications known toalter gastrointestinal function or inflammatory status during the study, untilcollection of faecal material
Exclusion
Exclusion Criteria:
Diagnosis of type 1 and/or type 2 diabetes
Diagnosed inflammatory bowel disease (IBD)
Current diagnosis of psychiatric disease/s or syndromes
Current diagnosis of neurodegenerative disease
Current pregnancy or breastfeeding
History of complicated gastrointestinal surgery
Systemic use of antibiotics and/or steroid medication in the last 4 months prior toinclusion
Regular use of any non-steroidal anti-inflammatory drug (NSAID) for the last 2months
Consumption of any NSAID within 3 days of sample collection
Current (or within the last 4 weeks prior to study start) use of probioticsupplementation
Any condition or intake of medication which could substantially interfere with theoutcome of the study, as decided by the principal investigator's discretion
After being included in the study and until collection of faecal material, startingany medication or treatment that could potentially influence the study participationand/or study analysis
Study Design
Study Description
Connect with a study center
Örebro University
Örebro,
SwedenActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.